ResMed's GAAP net income for 3M 2022 fiscal year was $203.613 million, up 14.2% from $178.372 million in the prior year. Revenue increased 20.2% to $904.015 million from $751.944 million a year earlier.
ResMed's GAAP net income for 3M 2022 fiscal year was $203.613 million, up 14.2% from $178.372 million in the prior year. Revenue increased 20.2% to $904.015 million from $751.944 million a year earlier. 
investor.resmed.com
English (US) 